Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.
Mary Gunn, PhD, MBA
Advertisement
Articles by Mary Gunn, PhD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2025 SCRS Global Site Solutions Summit: How Sponsors and CROs Can Streamline Feasibility to Support Sites
2
FDA Announces Ramifications of Government Shutdown Due to 2026 Lapse in Funding
3
2025 SCRS Global Site Solutions Summit: Scaling Success: Strategies For Sustainable Growth
4
2025 SCRS Global Site Solutions Summit: The Interoperability Challenges Sites Face With Clinical Trial Technology
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
